CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2014; 05(04): 168-170
DOI: 10.4103/0976-5042.150672
Case Report
Society of Gastrointestinal Endoscopy of India

A case of cutaneous scleroderma with primary sclerosing cholangitis

Nandeesh H. P.
Departments of Gastroenterology, J.S.S. Medical College & Hospital, Mysore, Karnataka, India
,
Jeevan H. R.
Departments of Gastroenterology, J.S.S. Medical College & Hospital, Mysore, Karnataka, India
,
Deepak Suvarna
Departments of Gastroenterology, J.S.S. Medical College & Hospital, Mysore, Karnataka, India
,
Chandra Babu D.
Departments of Gastroenterology, J.S.S. Medical College & Hospital, Mysore, Karnataka, India
,
Indrajit Suresh
Departments of Gastroenterology, J.S.S. Medical College & Hospital, Mysore, Karnataka, India
,
Subashchandra B. J.
1   Department of Gastroenterology, Medicine
,
Savitha T. C.
2   Department of Gastroenterology, Dermatology, J.S.S. Medical College & Hospital, Mysore, Karnataka, India
› Author Affiliations
Further Information

Publication History

Publication Date:
26 September 2019 (online)

Abstract

Sclerosing cholangitis comprises of a spectrum of cholestatic conditions that are characterized by patchy fibrosis, inflammation and destruction of intra hepatic and extrahepatic ducts. We report a case of a 42 year old woman who presented with darkening of skin with yellowish discolouration of the eyes. Clinical examination revealed icterus, taut skin with hepatosplenomegaly. Liver function tests showed a cholestatic picture. Skin biopsy showed features of cutaneous scleroderma. MRCP and Liver biopsy was suggestive of sclerosing cholangitis.

 
  • References

  • 1 Fraile G, Rodríguez-García JL, Moreno A. Primary sclerosing cholangitis associated with systemic sclerosis. Postgrad Med J 1991;67:189-92.
  • 2 Khurana V. Primary Sclerosing Cholangitis, Medscape; June, 2012.
  • 3 MacSween RN, Burt AD, Haboubi NY. Unusual variant of primary sclerosing cholangitis. J Clin Pathol 1987;40:541-5.
  • 4 Björnsson E, Chari ST, Smyrk TC, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007;45:1547-54.
  • 5 Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003;125:1364-9.
  • 6 Gluck M, Cantone NR, Brandabur JJ, Patterson DJ, Bredfeldt JE, Kozarek RA. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol 2008;42:1032-9.
  • 7 Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003;38:210-7.
  • 8 Rocco VK, Hurd ER. Scleroderma and scleroderma-like disorders. Semin Arthritis Rheum 1986;16:22-69.
  • 9 Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008;14:3948-55.
  • 10 Kallenberg CG, Van der Voort-Beelen JM, D’Amaro J, The TH. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol 1981;43:478-85.